Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Unicycive Therapeutics, Inc.

NASDAQ: UNCY · Life Sciences · 4 alerts · CIK 1766140

Share price
$3.70Close, Nov 16
Market cap
$108M
Shares outstanding
29.18MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Unicycive Therapeutics, Inc. filings on SEC EDGAR ↗

7:46 AM ET 8-K
Leadership Change

Unicycive Therapeutics Leadership Change

Unicycive Therapeutics appointed Meredith S. Manning as an independent director to its board, effective October 1, 2026. Ms. Manning, who previously served as Chief Commercial Officer of Soleno Therapeutics, will also serve as Chairperson of the Nominating and Corporate Governance Committee. The company also announced the resubmission of its New Drug Application for Oxylanthanum Carbonate with a new manufacturing vendor.

Counterparty
Meredith S. Manning

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.